Search clinical trials for: Androgen Independent
Total 2322 results
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
DendreonCompletedMetastatic Androgen Independent Prostate CancerUnited States, Canada
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
University of UtahBoston University; University of Pennsylvania; Northwestern University; Columbia... and other collaboratorsCompleted
-
BayerCompletedProstate CancerUnited States, Argentina
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDepression | Panic Disorder
-
University of ZurichSwiss National Science Foundation; University Hospital, Zürich; Besins Healthcare... and other collaboratorsTerminatedHypogonadism | Pre-frail SeniorsSwitzerland
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedProstate CancerUnited States
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
University Health Network, TorontoCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate Cancer | Metastatic CancerUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
AmgenCompletedHormone Refractory Prostate Cancer
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
University of Alabama at BirminghamNational Institute on Disability, Independent Living, and Rehabilitation...CompletedPhysically DisabledUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Aristotle University Of ThessalonikiCompletedPoor Ovarian Response | Androgen Receptor Gene Overexpression | Normal Responders | Bologna Criteria
-
Incyte CorporationTerminatedProstate CancerUnited States
-
NYU Langone HealthNovartisCompletedProstatic Neoplasms | Prostate CancerUnited States
-
Carolina Research Professionals, LLCBayerCompleted
-
OrfagenCompletedIdiopathic Solar UrticariaUnited States, United Kingdom
-
Assiut UniversityCompleted
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Novartis PharmaceuticalsCompleted
-
University of PittsburghOrtho Biotech, Inc.CompletedProstate CancerUnited States
-
DendreonCompleted
-
University of Southern CaliforniaNovartis; Genentech, Inc.CompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
SanofiRegeneron PharmaceuticalsCompletedProstatic Neoplasms | Neoplasm MetastasisUnited States, France, Canada, Brazil, Russian Federation, Ukraine, Australia, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Estonia, Singapore, Taiwan, Belgium, Czech Republic, Argentina, Denmark, Hungary, Israel, Italy, United Kingdom and more
-
NYU Langone HealthNovartisTerminatedProstatic Neoplasms | Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
Columbia UniversityCelgene CorporationCompletedProstate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
Merck Sharp & Dohme LLCAriad PharmaceuticalsCompleted
-
OnxeoCompleted
-
Institut Paoli-CalmettesTerminatedAndrogen-independent Prostate CancerFrance
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
University of Michigan Rogel Cancer CenterNovartisCompleted
-
Bostwick LaboratoriesProstate Institute of America; Community Memorial HealthCenter; HemaCare CorporationTerminated
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
Oncology Specialists, S.C.Wyeth is now a wholly owned subsidiary of PfizerCompletedProstate CancerUnited States
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
Oncology Specialists, S.C.Celgene CorporationCompletedProstate CancerUnited States
-
University of California, San FranciscoNovartisTerminated
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States